330 related articles for article (PubMed ID: 34090924)
1. Transgenic mouse models of breast cancer.
Regua AT; Arrigo A; Doheny D; Wong GL; Lo HW
Cancer Lett; 2021 Sep; 516():73-83. PubMed ID: 34090924
[TBL] [Abstract][Full Text] [Related]
2. A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse Models.
Lüönd F; Bill R; Vettiger A; Oller H; Pelczar P; Christofori G
J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):39-45. PubMed ID: 30209717
[TBL] [Abstract][Full Text] [Related]
3. Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism.
Mohapatra BC; Mirza S; Bele A; Gurumurthy CB; Raza M; Saleem I; Storck MD; Sarkar A; Kollala SS; Shukla SK; Southekal S; Wagner KU; Qiu F; Lele SM; Alsaleem MA; Rakha EA; Guda C; Singh PK; Cardiff RD; Band H; Band V
Mol Cancer Res; 2022 Sep; 20(9):1391-1404. PubMed ID: 35675041
[TBL] [Abstract][Full Text] [Related]
4. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
5. Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.
Gunaratna RT; Santos A; Luo L; Nagi C; Lambertz I; Spier M; Conti CJ; Fuchs-Young RS
Oncogene; 2019 May; 38(18):3535-3550. PubMed ID: 30651598
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC
Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211
[TBL] [Abstract][Full Text] [Related]
7. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
8. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.
Zhao Y; Kumbrink J; Lin BT; Bouton AH; Yang S; Toselli PA; Kirsch KH
Carcinogenesis; 2013 Dec; 34(12):2880-90. PubMed ID: 23825155
[TBL] [Abstract][Full Text] [Related]
9. A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer.
Hollern DP; Contreras CM; Dance-Barnes S; Silva GO; Pfefferle AD; Xiong J; Darr DB; Usary J; Mott KR; Perou CM
Breast Cancer Res Treat; 2019 Feb; 174(1):143-155. PubMed ID: 30484104
[TBL] [Abstract][Full Text] [Related]
10. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
11. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
[TBL] [Abstract][Full Text] [Related]
12. A transgenic mouse model for mammary carcinogenesis.
Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM
Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models.
Homer-Bouthiette C; Zhao Y; Shunkwiler LB; Van Peel B; Garrett-Mayer E; Baird RC; Rissman AI; Guest ST; Ethier SP; John MC; Powers PA; Haag JD; Gould MN; Smits BMG
BMC Cancer; 2018 Dec; 18(1):1233. PubMed ID: 30526553
[TBL] [Abstract][Full Text] [Related]
14. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
15. Mammary tumorigenesis and metastasis in transgenic mice.
Webster MA; Muller WJ
Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
18. Expression of activated oncogenes in the murine mammary gland: transgenic models for human breast cancer.
Muller WJ
Cancer Metastasis Rev; 1991 Oct; 10(3):217-27. PubMed ID: 1662559
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
[TBL] [Abstract][Full Text] [Related]
20. Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis.
Dourdin N; Schade B; Lesurf R; Hallett M; Munn RJ; Cardiff RD; Muller WJ
Cancer Res; 2008 Apr; 68(7):2122-31. PubMed ID: 18381417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]